RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Regional conduction velocities determined by noninvasive mapping are associated with arrhythmia-free survival after atrial fibrillation ablation
[EN] BACKGROUND Atrial arrhythmogenic substrate is a key determinant of atrial fibrillation (AF) recurrence after pulmonary vein
isolation (PVI), and reduced conduction velocities have been linked to adverse outcome. However, a noninvasive method to
assess such electrophysiologic substrate is not available to date.
OBJECTIVE This study aimed to noninvasively assess regional conduction velocities and their association with arrhythmia-free
survival after PVI.
METHODS A consecutive 52 patients scheduled for AF ablation (PVI only) and 19 healthy controls were prospectively included
and received electrocardiographic imaging (ECGi) to noninvasively determine regional atrial conduction velocities in sinus
rhythm. A novel ECGi technology obviating the need of additional computed tomography or cardiac magnetic resonance
imaging was applied and validated by invasive mapping.
RESULTS Mean ECGi-determined atrial conduction velocities were significantly lower in AF patients than in healthy controls
(1.45 6 0.15 m/s vs 1.64 6 0.15 m/s; P < .0001). Differences were particularly pronounced in a regional analysis considering
only the segment with the lowest average conduction velocity in each patient (0.8 6 0.22 m/s vs 1.08 6 0.26 m/s; P < .0001).
This average conduction velocity of the ¿slowest¿ segment was independently associated with arrhythmia recurrence and better
discriminated between PVI responders and nonresponders than previously proposed predictors, including left atrial size and late
gadolinium enhancement (magnetic resonance imaging). Patients without slow-conduction areas (mean conduction velocity
<0.78 m/s) showed significantly higher 12-month arrhythmia-free survival than those with 1 or more slow-conduction areas
(88.9% vs 48.0%; P 5 .002).
CONCLUSION This is the first study to investigate regional atrial conduction velocities noninvasively. The absence of
ECGi-determined slow-conduction areas well discriminates PVI responders from nonresponders. Such noninvasive assessment
of electrical arrhythmogenic substrate may guide treatment strategies and be a step toward personalized AF therapy., This work is supported in part by grants from the European Union s Horizon Research and Innovation
Programme under the Marie Sk1odowska-Curie Grant Agreement (860974; to M.S.G.); Instituto de Salud Carlos III, Spanish
Government, Madrid, Spain (FIS_PI16/00435 FIS_CIBER16; to L.M.); Ministerio de Ciencia e Innovación (supported by
FEDER Fondo Europeo de Desarrollo Regional PI17/01106, PEJ2018-003617, and RYC2018-024346-I; to A.M.C.), EIT
Health (SAVE-COR Activity code 220385, EIT Health is supported by EIT, a body of the European Union), Generalitat
Valenciana Conselleria d Educació, Investigació, Cultura i Esport (ACIF/2020/265; to A.C.), and Spanish Agencia Estatal
de Investigación (AEI), part of the Ministerio de Ciencia e Innovación, reference PID2020-119364RB-I00 (to A.C.).
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-119364RB-I00
,
European Commission / H2020 860974
,
Generalitat Valenciana ACIF/2020/265
,
Instituto de Salud Carlos III FIS_PI16/00435
,
Instituto de Salud Carlos III FIS_CIBER16
,
Ministerio de Ciencia RYC2018-024346-I
,
Innovación y Universidades 220385
,
EIT Health PI17/01106
,
Ministerio de Ciencia e Innovación PEJ2018-003617